209 related articles for article (PubMed ID: 3222488)
21. Expanding the reference dose concept to incorporate and optimize beneficial effects while preventing toxic responses from nonessential toxicants.
Calabrese EJ
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 2):S68-75. PubMed ID: 8921559
[TBL] [Abstract][Full Text] [Related]
22. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme.
Boogaard PJ; Hays SM; Aylward LL
Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039
[TBL] [Abstract][Full Text] [Related]
23. Comparison of noncancer risk assessment approaches for use in deriving drinking water criteria.
Gibson MC; deMonsabert SM; Orme-Zavaleta J
Regul Toxicol Pharmacol; 1997 Dec; 26(3):243-56. PubMed ID: 9441915
[TBL] [Abstract][Full Text] [Related]
24. Human health risk assessment of endosulfan: II. Dietary exposure assessment.
Silva MH; Carr WC
Regul Toxicol Pharmacol; 2010 Feb; 56(1):18-27. PubMed ID: 19733202
[TBL] [Abstract][Full Text] [Related]
25. Toxicology and human health assessment of decabromodiphenyl ether.
Hardy ML; Banasik M; Stedeford T
Crit Rev Toxicol; 2009 Nov; 39 Suppl 3():1-44. PubMed ID: 19874087
[TBL] [Abstract][Full Text] [Related]
26. Human health risk assessment of endosulfan. Part III: Occupational handler exposure and risk.
Beauvais SL; Silva MH; Powell S
Regul Toxicol Pharmacol; 2010 Feb; 56(1):28-37. PubMed ID: 19854234
[TBL] [Abstract][Full Text] [Related]
27. Biomonitoring equivalents for 2,2',4,4',5-pentabromodiphenylether (PBDE-99).
Krishnan K; Adamou T; Aylward LL; Hays SM; Kirman CR; Nong A
Regul Toxicol Pharmacol; 2011 Jul; 60(2):165-71. PubMed ID: 21466829
[TBL] [Abstract][Full Text] [Related]
28. Framework for metals risk assessment.
Fairbrother A; Wenstel R; Sappington K; Wood W
Ecotoxicol Environ Saf; 2007 Oct; 68(2):145-227. PubMed ID: 17889701
[TBL] [Abstract][Full Text] [Related]
29. Purpose-Driven Risk Assessment.
Lipscomb JC
Toxicol Pathol; 2019 Dec; 47(8):1027-1034. PubMed ID: 31581901
[TBL] [Abstract][Full Text] [Related]
30. Assessing human health response in life cycle assessment using ED10s and DALYs: part 1--Cancer effects.
Crettaz P; Pennington D; Rhomberg L; Brand K; Jolliet O
Risk Anal; 2002 Oct; 22(5):931-46. PubMed ID: 12442990
[TBL] [Abstract][Full Text] [Related]
31. Low dose responses.
Wilson R
Risk Anal; 2000 Jun; 20(3):297-9. PubMed ID: 10949407
[No Abstract] [Full Text] [Related]
32. Uncertainties in the reference dose for methylmercury.
Dourson ML; Wullenweber AE; Poirier KA
Neurotoxicology; 2001 Oct; 22(5):677-89. PubMed ID: 11770889
[TBL] [Abstract][Full Text] [Related]
33. Risk assessment initiatives for noncancer endpoints: implications for risk characterization of chemical mixtures.
DeRosa CT; Dourson ML; Osborne R
Toxicol Ind Health; 1989 Oct; 5(5):805-24. PubMed ID: 2683224
[TBL] [Abstract][Full Text] [Related]
34. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
Kavlock R; Dix D
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
[TBL] [Abstract][Full Text] [Related]
35. The unsteady state and inertia of chemical regulation under the US Toxic Substances Control Act.
Krimsky S
PLoS Biol; 2017 Dec; 15(12):e2002404. PubMed ID: 29252997
[TBL] [Abstract][Full Text] [Related]
36. Informing 21st-Century Risk Assessments with 21st-Century Science.
Birnbaum LS; Burke TA; Jones JJ
Environ Health Perspect; 2016 Apr; 124(4):A60-3. PubMed ID: 27035154
[TBL] [Abstract][Full Text] [Related]
37. Hierarchical dose-response modeling for high-throughput toxicity screening of environmental chemicals.
Wilson A; Reif DM; Reich BJ
Biometrics; 2014 Mar; 70(1):237-46. PubMed ID: 24397816
[TBL] [Abstract][Full Text] [Related]
38. Toxicity testing in the 21st century: how will it affect risk assessment?
Rhomberg LR
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):361-75. PubMed ID: 20574908
[TBL] [Abstract][Full Text] [Related]
39. Improving the use of epidemiologic data in health risk assessment.
Erdreich LS; Burnett C
Toxicol Ind Health; 1985 Dec; 1(4):65-81. PubMed ID: 3843512
[TBL] [Abstract][Full Text] [Related]
40. Advancing exposure characterization for chemical evaluation and risk assessment.
Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
